Learn More
Enzo Life Sciences Glucagon like peptide 1 (human) (1-36) amide (100µg)

Supplier: Enzo Life Sciences BMLGP14370100
A predominant cleaved form of pro-glucagon found in the pancreas and central nervous system. It has been reported that human pancreatic endocrine tumours contain molecular forms of GLP-1 which resemble those expressed in the small intestine, rather than in their tissue of origin. Within the CNS, GLP-1 powerfully inhibits feeding in fasting rats, an action which is blocked by prior administration of the GLP-1 receptor antagonist exendin [9-39]. This observation led to the suggestion that central GLP-1 is a physiological mediator of satiety and has projected GLP-1 into the obesity control debate. Glucagon-like peptide (GLP) 1 [1-36] also serves as a control peptide for Anti-Glucagon-like Peptide (GLP) 1 (BML-GA1176). Blocks immunoreactivity at 10 nmol per ml diluted antibody. Alternative name: GLP 1 (1-36) amide, Blocking peptide for Glucagon like peptide 1 pAb (BML-GA1176). Purity: ≥95%. Solubility: Soluble in water at 1mg/mL. Long Term Storage: -20°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.